| Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity PL Minciullo, A Catalano, G Mandraffino, M Casciaro, A Crucitti, ... Archivum immunologiae et therapiae experimentalis 64, 111-126, 2016 | 462 | 2016 |
| Left ventricular function in hypertension: new insight by speckle tracking echocardiography E Imbalzano, C Zito, S Carerj, G Oreto, G Mandraffino, M Cusmà‐Piccione, ... Echocardiography 28 (6), 649-657, 2011 | 198 | 2011 |
| Adverse drug reactions in hospitalized patients: results of the FORWARD (Facilitation of Reporting in Hospital Ward) study C Giardina, PM Cutroneo, E Mocciaro, GT Russo, G Mandraffino, G Basile, ... Frontiers in pharmacology 9, 350, 2018 | 178 | 2018 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 177 | 2021 |
| Pulse wave velocity and augmentation index, but not intima‐media thickness, are early indicators of vascular damage in hypercholesterolemic children S Riggio, G Mandraffino, MA Sardo, R Iudicello, N Camarda, E Imbalzano, ... European journal of clinical investigation 40 (3), 250-257, 2010 | 164 | 2010 |
| Endothelial progenitor cells for diagnosis and prognosis in cardiovascular disease CO Aragona, E Imbalzano, F Mamone, V Cairo, A Lo Gullo, A D’Ascola, ... Stem cells international 2016, 2016 | 100 | 2016 |
| Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study A Pirillo, K Garlaschelli, M Arca, M Averna, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 17-24, 2017 | 78 | 2017 |
| Familial hypercholesterolemia: the Italian atherosclerosis society network (LIPIGEN) M Averna, AB Cefalu, M Casula, D Noto, M Arca, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 11-16, 2017 | 74 | 2017 |
| Vitamin D status in rheumatoid arthritis: inflammation, arterial stiffness and circulating progenitor cell number A Lo Gullo, G Mandraffino, G Bagnato, CO Aragona, E Imbalzano, ... PLoS One 10 (8), e0134602, 2015 | 57 | 2015 |
| Smoke exposure and circulating progenitor cells: evidence for modulation of antioxidant enzymes and cell count G Mandraffino, MA Sardo, S Riggio, A D'Ascola, S Loddo, A Alibrandi, ... Clinical biochemistry 43 (18), 1436-1442, 2010 | 53 | 2010 |
| Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness MA Sardo, S Campo, G Mandraffino, C Saitta, A Bonaiuto, M Castaldo, ... Clinical chemistry 54 (5), 814-823, 2008 | 53 | 2008 |
| Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study M Casula, E Olmastroni, A Pirillo, AL Catapano, M Arca, M Averna, ... Atherosclerosis 277, 413-418, 2018 | 51 | 2018 |
| Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two–Lipid Center Real … G Mandraffino, R Scicali, J Rodriguez-Carrio, F Savarino, F Mamone, ... Journal of clinical lipidology 14 (2), 231-240, 2020 | 42 | 2020 |
| Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation A Lo Gullo, J Rodríguez-Carrio, CO Aragona, G Dattilo, C Zito, A Suárez, ... Atherosclerosis 271, 214-222, 2018 | 41 | 2018 |
| Practical aspects in the management of statin-associated muscle symptoms (SAMS) U Laufs, KJ Filipiak, I Gouni-Berthold, AL Catapano, G Mandraffino, ... Atherosclerosis Supplements 26, 45-55, 2017 | 39 | 2017 |
| Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress A Lo Gullo, G Mandraffino, MA Sardo, A D’Ascola, F Mamone, S Loddo, ... Scandinavian journal of rheumatology 43 (3), 184-193, 2014 | 39 | 2014 |
| Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness G Mandraffino, MA Sardo, S Riggio, S Loddo, E Imbalzano, A Alibrandi, ... Hypertension Research 34 (7), 876-883, 2011 | 39 | 2011 |
| Hyaluronan in the experimental injury of the cartilage: biochemical action and protective effects A Avenoso, A D’Ascola, M Scuruchi, G Mandraffino, A Calatroni, A Saitta, ... Inflammation Research 67, 5-20, 2018 | 37 | 2018 |
| Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement G Mandraffino, E Imbalzano, MA Sardo, A D'Ascola, F Mamone, ... Journal of Human Hypertension 28 (9), 543-550, 2014 | 37 | 2014 |
| Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review E Imbalzano, G Mandraffino, M Casciaro, S Quartuccio, A Saitta, ... Heart failure reviews 21, 463-473, 2016 | 34 | 2016 |
Egidio ImbalzanoUniversity of MessinaVerified email at unime.it
